Ann: ASX Conditional Approval to Lift Suspension, page-38

I agree, SW. Craig's got a lot of ground to make up here. All they were after from the IPO was a lousy US$10M. I'm still struggling to comprehend why they weren't able to generate sufficient interest to make that possible. Obviously, the broker roadshow/bookbuild wasn't convincing enough. I still have a niggle in the back of my mind that there's a predator somewhere in the mix. The gold-standard IP would be worth a lot to the right pharma.

I'm glad Craig and Niall are stumping up a significant part of the capital required. That's a good first step. Mind you, the absence of alternatives left them no choice.

I'm looking forward to the webinar on Thursday. Hopefully it will answer many of the questions I'm sure we all have and show a clear and achievable path forward.

Just to be clear, I'm not down on Craig or the company. Just been here too many times before at significant personal and financial cost, and have now, belatedly but thankfully, become more hardheaded and realistic v. uncritically optimistic about such things.

I wish the best to us all for a more successful '24. That includes Craig and Niall.